SynthesisFrontiers in pharmacology2024

A meta-analysis of the efficacy of programmed cell death 1/its ligand inhibitors plus cytotoxic T-lymphocyte-associated antigen 4 inhibitors in non-small cell lung cancer.

Li Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.